Tzield™ (teplizumab-mzwv) approved by fda as the first and only treatment indicated to delay the onset of stage 3 type 1 diabetes (t1d) in adult and pediatric patients aged 8 years and older with stage 2 t1d
Tzield is the first disease-modifying therapy in t1d, a life-threatening autoimmune disease in a clinical trial, in stage 2 t1d patients, tzield delayed the median onset of stage 3 t1d by 25 months, or approximately 2 years, compared to placebo stage 3 t1d is associated with significant health risks, including diabetic ketoacidosis, which can be life threatening patients who progress to stage 3 t1d eventually require insulin injections for life investor conference call at 8:00am et tomorrow red bank, n.j. , nov. 17, 2022 /prnewswire/ -- provention bio, inc. (nasdaq: prvb) (the "company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that the united states food and drug administration (fda) approved the biologics license application (bla) for tzield (teplizumab-mzwv), an anti-cd3-directed antibody, for intravenous use, as the first and only immunomodulatory treatment to delay the onset of stage 3 t1d in adult and pediatric patients aged 8 years and older with stage 2 t1d.
PRVB Ratings Summary
PRVB Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission